HelloJust thinking about the new offering which comes after a...

Hello

Just thinking about the new offering which comes after a short period of the last offering . And im guessing SSH will dip into the aspire deal once every quarter for more funds .

My question is , does this indicate that SSH board/management believe we can go through the trial ( 2 1/2 years ) self funded without a buyout or a partnership .

( only partnerships would be in europe with distribution centers )

The very positive scenario for us if this does happen and milestones are met + and the trial goes well + any positive updates on the fully implantable

is that we can reach the levels of heartware (* market price ) by the end of 2014 - a price approaching 100 usd .

I believe if we were to have a buyout anytime till the end of this year price would be 20-35 . As this has been a long term investment id believe its worth the wait till the end and settling for prices closer to 100 !


- So is the constant offerings to go it alone till gaining fda approval a couple of years from now ?

or

Who is buying the stock offering through aspire , is there a hint of a buyout round the corner ?